Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals (ACXP) Stock Price & Analysis


ACXP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.33 - $4.85
Previous Close$2.9
Average Volume (3M)28.52K
Market Cap
Enterprise Value$26.65M
Total Cash (Recent Filing)$7.20M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-2.6
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding11,671,795
10 Day Avg. Volume21,927
30 Day Avg. Volume28,525
Standard Deviation0.14
Financial Highlights & Ratios
Price to Book (P/B)6.48
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.16
Price Target Upside352.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Acurx Pharmaceuticals’s price range in the past 12 months?
Acurx Pharmaceuticals lowest stock price was $2.33 and its highest was $4.85 in the past 12 months.
    What is Acurx Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Acurx Pharmaceuticals’s upcoming earnings report date?
    Acurx Pharmaceuticals’s upcoming earnings report date is Aug 14, 2023 which is in 75 days.
      How were Acurx Pharmaceuticals’s earnings last quarter?
      Acurx Pharmaceuticals released its earnings results on May 12, 2023. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.235 by -$0.015.
        Is Acurx Pharmaceuticals overvalued?
        According to Wall Street analysts Acurx Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Acurx Pharmaceuticals pay dividends?
          Acurx Pharmaceuticals does not currently pay dividends.
          What is Acurx Pharmaceuticals’s EPS estimate?
          Acurx Pharmaceuticals’s EPS estimate is -$0.23.
            How many shares outstanding does Acurx Pharmaceuticals have?
            Acurx Pharmaceuticals has 11,671,795 shares outstanding.
              What happened to Acurx Pharmaceuticals’s price movement after its last earnings report?
              Acurx Pharmaceuticals reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.235. Following the earnings report the stock price went down -8.459%.
                Which hedge fund is a major shareholder of Acurx Pharmaceuticals?
                Currently, no hedge funds are holding shares in ACXP


                Acurx Pharmaceuticals Stock Smart Score

                The Acurx Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Acurx Pharmaceuticals

                Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.


                Top 5 ETFs holding ACXP

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold ACXP. The ETFs are listed according to market value of ACXP within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Cyclerion Therapeutics
                Gain Therapeutics
                Applied Molecular Transport

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis